2022 Q4 Form 10-K Financial Statement

#000168316822008295 Filed on December 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022
Revenue $101.7K $61.83K $427.7K
YoY Change
Cost Of Revenue $118.5K $224.9K $556.7K
YoY Change
Gross Profit -$16.76K -$163.0K -$129.0K
YoY Change
Gross Profit Margin -16.48% -263.67% -30.17%
Selling, General & Admin $348.7K $427.3K $1.574M
YoY Change -47.49% 348.81% 1093.76%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $59.05K -$4.670K $3.125K
YoY Change
% of Gross Profit
Operating Expenses $475.1K $427.3K $1.585M
YoY Change -28.45% 348.82% 1102.51%
Operating Profit -$491.9K -$590.3K -$1.714M
YoY Change -25.92% 1200.45%
Interest Expense $4.290K -$94.88K -$291.1K
YoY Change -109.6% 1124.26% 1198.17%
% of Operating Profit
Other Income/Expense, Net $21.23K -$12.25K -$291.0K
YoY Change -147.48% 1197.93%
Pretax Income -$470.7K -$697.4K -$2.005M
YoY Change -33.59% 577.46% 1200.07%
Income Tax
% Of Pretax Income
Net Earnings -$470.7K -$697.4K -$2.005M
YoY Change -33.59% 577.46% 1200.07%
Net Earnings / Revenue -462.72% -1128.0% -468.88%
Basic Earnings Per Share -$0.01 -$0.05
Diluted Earnings Per Share -$0.01 -$14.93K -$0.05
COMMON SHARES
Basic Shares Outstanding 48.71M shares 47.10M shares 43.11M shares
Diluted Shares Outstanding 48.69M shares 43.11M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $180.7K $392.6K $392.6K
YoY Change 27.16% 79.46% 79.46%
Cash & Equivalents $180.6K $392.6K $392.6K
Short-Term Investments
Other Short-Term Assets $5.000K $5.000K $5.000K
YoY Change
Inventory
Prepaid Expenses $5.000K $5.000K
Receivables $865.8K $491.4K $491.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.051M $888.9K $889.0K
YoY Change 640.12% 306.4% 306.4%
LONG-TERM ASSETS
Property, Plant & Equipment $410.2K $21.88K $21.88K
YoY Change -94.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $987.4K
YoY Change
Other Assets $4.402M $6.531M $6.531M
YoY Change 131.14% 1428.44% 1428.44%
Total Long-Term Assets $7.155M $7.085M $7.085M
YoY Change 275.7% 1558.16% 1558.18%
TOTAL ASSETS
Total Short-Term Assets $1.051M $888.9K $889.0K
Total Long-Term Assets $7.155M $7.085M $7.085M
Total Assets $8.206M $7.974M $7.974M
YoY Change 300.99% 1134.33% 1134.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.73K $84.76K $84.76K
YoY Change 80.17% 2203.29% 2203.26%
Accrued Expenses $4.810K $0.00 $0.00
YoY Change -93.0% -100.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $400.0K $0.00 $0.00
YoY Change -77.11% -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $775.6K $317.7K $317.7K
YoY Change -57.95% 11.28% 11.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $421.8K $252.3K $252.3K
YoY Change
Total Long-Term Liabilities $421.8K $252.3K $252.3K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $775.6K $317.7K $317.7K
Total Long-Term Liabilities $421.8K $252.3K $252.3K
Total Liabilities $1.197M $570.0K $570.0K
YoY Change -35.09% 99.66% 99.66%
SHAREHOLDERS EQUITY
Retained Earnings -$2.937M -$2.467M
YoY Change 434.66%
Common Stock $4.878K $4.861K
YoY Change 20.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.009M $7.404M $7.404M
YoY Change
Total Liabilities & Shareholders Equity $8.206M $7.974M $7.974M
YoY Change 300.99% 1134.33% 1134.34%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022
OPERATING ACTIVITIES
Net Income -$470.7K -$697.4K -$2.005M
YoY Change -33.59% 577.46% 1200.07%
Depreciation, Depletion And Amortization $59.05K -$4.670K $3.125K
YoY Change
Cash From Operating Activities -$1.183M -$1.333M -$1.629M
YoY Change 1601.55% 3253.36% 2033.63%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$3.680M $6.107M
YoY Change -100.0% 761.33% -1529.28%
Acquisitions
YoY Change
Other Investing Activities $571.0K
YoY Change
Cash From Investing Activities $571.0K -$3.680M -$6.107M
YoY Change -138.66% 761.33% 1329.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $400.0K 4.906M $7.910M
YoY Change -72.79% 619.04% 997.96%
NET CHANGE
Cash From Operating Activities -$1.183M -1.333M -$1.629M
Cash From Investing Activities $571.0K -3.680M -$6.107M
Cash From Financing Activities $400.0K 4.906M $7.910M
Net Change In Cash -$211.9K -107.4K $173.8K
YoY Change 176.38% -149.88% -19.83%
FREE CASH FLOW
Cash From Operating Activities -$1.183M -$1.333M -$1.629M
Capital Expenditures $0.00 -$3.680M $6.107M
Free Cash Flow -$1.183M $2.348M -$7.737M
YoY Change -184.04% 505.73% -2304.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
491395 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
218737 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5000 usd
CY2022Q1 dei Entity Public Float
EntityPublicFloat
22641290 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48706915 shares
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001829311
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-56220
CY2022 dei Entity Registrant Name
EntityRegistrantName
BITMINE IMMERSION TECHNOLOGIES, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3986354
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2030 Powers Ferry Road SE
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 212
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
CY2022 dei City Area Code
CityAreaCode
(404)
CY2022 dei Local Phone Number
LocalPhoneNumber
816-8240
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
392550 usd
CY2021Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
0 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
888945 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
218737 usd
CY2022Q3 NONE Cryptocurrency
Cryptocurrency
21434 usd
CY2021Q3 NONE Cryptocurrency
Cryptocurrency
0 usd
CY2022Q3 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
532345 usd
CY2021Q3 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
0 usd
CY2022Q3 NONE Fixed Assets Net
FixedAssetsNet
21875 usd
CY2021Q3 NONE Fixed Assets Net
FixedAssetsNet
0 usd
CY2022Q3 NONE Fixed Assets Not In Service
FixedAssetsNotInService
6509602 usd
CY2021Q3 NONE Fixed Assets Not In Service
FixedAssetsNotInService
427296 usd
CY2022Q3 us-gaap Assets
Assets
7974201 usd
CY2021Q3 us-gaap Assets
Assets
646033 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
84761 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3680 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
0 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
4505 usd
CY2022Q3 NONE Loans Payable Related Party
LoansPayableRelatedParty
0 usd
CY2021Q3 NONE Loans Payable Related Party
LoansPayableRelatedParty
277296 usd
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
232913 usd
CY2021Q3 us-gaap Deferred Revenue
DeferredRevenue
0 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
317673 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
285481 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
252322 usd
CY2021Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 usd
CY2022Q3 us-gaap Liabilities
Liabilities
569995 usd
CY2021Q3 us-gaap Liabilities
Liabilities
285481 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48606915 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48606915 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40433399 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40433399 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
4861 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
4043 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9865866 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
817842 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2466566 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-461334 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7404205 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
360551 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7974201 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
646033 usd
CY2022 us-gaap Revenues
Revenues
427668 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
556699 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Gross Profit
GrossProfit
-129030 usd
CY2021 us-gaap Gross Profit
GrossProfit
0 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
227597 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
63815 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
856925 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
0 usd
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
489096 usd
CY2021 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
68000 usd
CY2022 NONE Impairment Of Cryptocurrency
ImpairmentOfCryptocurrency
11535 usd
CY2021 NONE Impairment Of Cryptocurrency
ImpairmentOfCryptocurrency
0 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1585154 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
131815 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1714184 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-131815 usd
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
291048 usd
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
22424 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-291048 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22424 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2005233 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-154239 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43107688 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43107688 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9758184 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9758184 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-50075 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
493615 usd
CY2021 NONE Stock Based Compensation Related Party Value
StockBasedCompensationRelatedPartyValue
67500 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3750 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-154239 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
360551 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
360551 usd
CY2022 NONE Stock Based Compensation Related Party Value
StockBasedCompensationRelatedPartyValue
108741 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3039662 usd
CY2022 NONE Series Preferred For Services Related Party
SeriesPreferredForServicesRelatedParty
0 usd
CY2022 NONE Common Stock Issued For Services Related Party
CommonStockIssuedForServicesRelatedParty
110000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
637964 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5152500 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2005233 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7404205 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2005233 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-154239 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
856724 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
71250 usd
CY2022 us-gaap Depreciation
Depreciation
3125 usd
CY2021 us-gaap Depreciation
Depreciation
0 usd
CY2022 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
1023741 usd
CY2021 us-gaap Increase Decrease In Notes Receivables
IncreaseDecreaseInNotesReceivables
-0 usd
CY2022 NONE Increase Decrease In Cryptocurrencies
IncreaseDecreaseInCryptocurrencies
21434 usd
CY2021 NONE Increase Decrease In Cryptocurrencies
IncreaseDecreaseInCryptocurrencies
-0 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
81081 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
3680 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
485234 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
2948 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1629243 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76361 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6107306 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
427296 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6107306 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-427296 usd
CY2022 NONE Common Shares Sold In Private Placement
CommonSharesSoldInPrivatePlacement
5152500 usd
CY2021 NONE Common Shares Sold In Private Placement
CommonSharesSoldInPrivatePlacement
493615 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2757861 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
226849 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7910361 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
720464 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
173812 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
216807 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218737 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1930 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
392550 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
218737 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zeABDG9yxJXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zsH6wer196V9">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The most significant estimates relate to the calculation of stock-based compensation, useful lives and recoverability of long-lived assets, income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates. There have been no material changes to the Company’s accounting estimates since the Company’s financial statements for the fiscal year ended August 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2744108 usd
CY2022Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
295554 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
392550 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
218737 usd
CY2022 NONE Impairment Of Cryptocurrency
ImpairmentOfCryptocurrency
11535 usd
CY2022Q3 NONE Fixed Assets Not In Service
FixedAssetsNotInService
6509602 usd
CY2021Q3 NONE Fixed Assets Not In Service
FixedAssetsNotInService
427296 usd
CY2022 us-gaap Equipment Expense
EquipmentExpense
25000 usd
CY2021 us-gaap Equipment Expense
EquipmentExpense
0 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3125 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2021Q3 NONE Cryptocurrency
Cryptocurrency
0 usd
CY2022 NONE Revenue Received From Hosting And Self Mining
RevenueReceivedFromHostingAndSelfMining
32969 usd
CY2022 NONE Impairment Of Cryptocurrency
ImpairmentOfCryptocurrency
11535 usd
CY2022Q3 NONE Cryptocurrency
Cryptocurrency
21434 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48606915 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40433399 shares
CY2022Q1 us-gaap Share Price
SharePrice
1.25
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
427669 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
-0 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3125 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2022Q3 us-gaap Notes Receivable Net
NotesReceivableNet
1023741 usd
CY2021Q3 us-gaap Notes Receivable Net
NotesReceivableNet
0 usd
CY2022 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
168750 usd
CY2022Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
168750 usd
CY2022Q1 NONE Purchase Price
PurchasePrice
337500 usd
CY2022Q1 us-gaap Notes Payable
NotesPayable
168750 usd
CY2022Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
168750 usd
CY2022Q3 us-gaap Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
0.075 pure
CY2022 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
3039662 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.25
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0004 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.233 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
-0 pure
CY2022Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
10
CY2022Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
2000000 usd
CY2022 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
3039662 usd
CY2022 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
303966 shares

Files In Submission

Name View Source Status
0001683168-22-008295-index-headers.html Edgar Link pending
0001683168-22-008295-index.html Edgar Link pending
0001683168-22-008295.txt Edgar Link pending
0001683168-22-008295-xbrl.zip Edgar Link pending
bitmine_ex3101.htm Edgar Link pending
bitmine_ex3102.htm Edgar Link pending
bitmine_ex3201.htm Edgar Link pending
bitmine_ex3202.htm Edgar Link pending
bitmine_i10k-083122.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
none-20220831.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
none-20220831_pre.xml Edgar Link unprocessable
none-20220831_lab.xml Edgar Link unprocessable
none-20220831_cal.xml Edgar Link unprocessable
bitmine_i10k-083122_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20220831_def.xml Edgar Link unprocessable